α-amido boronic acids: A synthetic challenge and their properties as serine protease inhibitors

Medicinal Research Reviews

Volumn 28, Issue 2, 2008, Pages 233-246

  Matteson, Donald S ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Amido boronic acid; Amino boronic acid; Boronic acid; Cancer treatment; Serine protease

Indexed keywords

ALPHA AMIDO BORONIC ACID; BORONIC ACID DERIVATIVE; BORTEZOMIB; ENZYME INHIBITOR; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

CHEMICAL STRUCTURE; DRUG SYNTHESIS; REVIEW; STRUCTURE ACTIVITY RELATION;

BORONIC ACIDS; PYRAZINES; SERINE PROTEINASE INHIBITORS;

EID: 39549106056     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.20105     Document Type: Review

References (60)

1. Matteson DS, Sadhu KM, Lienhard GE. (R)-1-Acetamido-2- phenylethaneboronic acid. A specific transition-state analogue for chymotrypsin. J Am Chem Soc 1981;103:5241-5242.
2. (a) Yang W, Gao X, Wang B. Boronic acid compounds as potential pharmaceutical agents. Med Res Rev 2003;23:346-368.
3. (b) Dembitsky VM, Quntar AAA, Srebnik M. Recent advances in the medicinal chemistry of α-aminoboronic acids, amine-carboxyboranes and their derivatives. Mini Rev Med Chem 2004;4:1001-1018.
4. (a) Adams J, Behnke M, Chen S, Cruickshank AA, Dick LR, Grenier L, Klunder JM, Ma Y-T, Plamondon L, Stein RL. Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids. Bioorganic & Medicinal Chemistry Letters 1998;8:333-338.
5. (b) Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S, Elliott PJ. Proteasome inhibitors: A novel class of potent and effective antitumor agents. Cancer Research 1999;59:2615-2622.
6. (c) Adams J. Development of the proteasome inhibitor PS-341. Oncologist 2002;7:9-16.
7. (a) Matteson DS. Radical catalyzed additions to dibutyl ethyleneboronate. J Am Chem Soc 1959;81:5004.
8. (b) Matteson DS. Radical-catalyzed additions to α,β- unsaturated boronic esters. J Am Chem Soc 1960;82:4228-4233.
9. Matteson DS, Mah RWH. Neighboring boron in nucleophilic displacement. J Am Chem Soc 1963;85:2599-2603.
10. (a) Matteson DS, Cheng TC. Dibutyl iodomethaneboronate. J Organomet Chem 1966;6:100-101.
11. (b) Matteson DS, Cheng TC. Displacement reactions of dibutyl iodomethaneboronate and the synthesis of boron-substituted pyrimidines. J Org Chem 1968;33:3055-3060.
12. Koehler KA, Lienhard GE. 2-Phenylethaneboronic acid, a possible transition-state analog for chymotrypsin. Biochemistry 1971;10:2477-2483.
13. Matteson DS, Jesthi PK. A new synthesis of an α-haloalkaneboronic ester, 1-bromo-1-ethylenedioxyboryl-2-phenylethane, and a supervenient synthesis of a 1,2-diboronic ester, 1,2-bis(ethylenedioxyboryl)-1-phenylethane. J Organomet Chem 1976;114:1-7.
14. (a) Matteson DS, Arne K. Carbanions from deprotonation of α-(phenylthio)alkaneboronic esters. J Am Chem Soc 1978;100:1325-1326.
15. (b) Matteson DS, Arne KH. Carbanions from α-phenylthio boronic esters as synthetic intermediates. Organometallics 1982;1:280-288.
16. Matteson DS, Majumdar D. Iodomethaneboronic esters and aminomethaneboronic esters. J Organomet Chem 1979;170:259-264.
17. Matteson DS, Majumdar D. Homologation of boronic esters with trimethylsilylchloromethyllithium. J Organomet Chem 1980;184:C41-C43.
18. Rathke MW, Chao E, Wu G. The preparation and reactions of esters of dichloromethaneboronic acid. J Organomet Chem 1976;122:145-149.
19. (a) Matteson DS, Majumdar D. α-chloro boronic esters from homologation of boronic esters. J Am Chem Soc 1980;102:7588-7590.
20. (b) Matteson DS, Majumdar D. Homologation of boronic esters to α-chloro boronic esters. Organometallics 1983;2:1529-1535.
21. (a) Corey EJ, Jautelat M, Oppolzer W. New route to sulfonium ylides. Diphenylsulfonium isopropylide. Tetrahedron Lett 1967; 2325-2328.
22. (b) Taguchi H, Yamamoto H, Nozaki H. Practical synthesis of polyhalomethyllithium carbonyl adducts. J Am Chem Soc 1974;96:3010-3011.
23. Ray R, Matteson DS. Osmium tetroxide catalyzed hydroxylation of hindered olefins. Tetrahedron Lett 1980;21:449-450.
24. (a) Matteson DS, Ray R. Directed chiral synthesis with pinanediol boronic esters. J Am Chem Soc 1980;102:7590-7591.
25. (b) Matteson DS, Ray R, Rocks RR, Tsai DJS. Directed chiral synthesis by way of α-chloro boronic esters. Organometallics 1983;2:1536-1543.
26. Tsai DJS, Jesthi PK, Matteson DS. Diastereoselection in reactions of pinanediol dichloromethaneboronate. Organometallics 1983;2:1543-1545.
27. Matteson DS, Sadhu KM. Synthesis of 1-amino-2-phenylethane-1-boronic acid derivatives. Organometallics 1984;3:614-618.
28. Matteson DS, Jesthi PK, Sadhu KM. Synthesis and properties of pinanediol α-amido boronic esters. Organometallics 1984;3:1284-1288.
29. Kettner CA, Shenvi AB. Inhibition of the serine proteases leukocyte elastase, pancreatic elastase, cathepsin G, and chymotrypsin by peptide boronic acids. J Biol Chem 1984;259:15106-15114.
30. Matteson DS, Michnick TJ. Synthesis of (1R)-(1-acetamido-2- phenylethyl)boronic acid-1-13C. J Labelled Cpds Radiopharm 1992;31:567-573.
31. (a) Matteson DS. Asymmetric synthesis with boronic esters. Acc Chem Res 1988;21:294-300.
32. (b) Matteson DS. α-halo boronic esters: Intermediates for stereodirected synthesis. Chem Rev 1989;89:1535-1551.
33. Lindquist RN, Nguyen AC. Aminomethaneboronic acids. Synthesis and inhibition of a boron analog of esterase substrates. J Am Chem Soc 1977;99:6435-6437.
34. Amiri P, Lindquist RN, Matteson DS, Sadhu KM. Benzamidomethaneboronic acid: Synthesis and inhibition of chymotrypsin. Arch Biochem Biophys 1984;234:531-536.
35. Kinder DH, Katzenellenbogen JA. Acylamido boronic acids and difluoroborane analogs of amino acids: Potent inhibitors of chymotrypsin and elastase. J Med Chem 1985;28:1917-1925.
36. Kettner CA, Bone R, Agard DA, Bachovchin WW. Kinetic properties of the binding of α-lytic protease to peptide boronic acids. Biochemistry 1988;27:7682-7688.
37. (a) Soskel NT, Watanabe S, Hardie R, Shenvi AB, Punt JA, Kettner CA. Effects of dosage and timing of administration of a peptide boronic acid inhibitor on lung mechanics and morphometrics in elastase-induced emphysema in hamsters. Am Rev Resp Dis 1986;133:635-638.
38. (b) Soskel NT, Watanabe S, Hardie R, Shenvi AB, Punt JA, Kettner CA. A new peptide boronic acid inhibitor of elastase-induced lung injury in hamsters. Am Rev Resp Dis 1986;133:639-642.
39. Bone R, Shenvi AB, Kettner CA, Agard DA. Serine protease mechanism: Structure of an inhibitory complex of α-lytic protease and a tightly bound peptide boronic acid. Biochemistry 1987;26:7609-7614.
40. (a) Bachovchin WW, Wong WYL, Farr-Jones S, Shenvi AB, Kettner CA. Nitrogen-15 NMR spectroscopy of the catalytic-triad histidine of a serine protease in peptide boronic acid inhibitor complexes. Biochemistry 1988;27:7689-7697.
41. (b) Bone R, Frank D, Kettner CA, Agard DA. Structural analysis of specificity: α-lytic protease complexes with analogs of reaction intermediates. Biochemistry 1989;28:7600-7609.
42. (c) Tsilikounas E, Kettner CA, Bachovchin WW. Boron-11 NMR spectroscopy of peptide boronic acid inhibitor complexes of α-lytic protease. Direct evidence for tetrahedral boron in both boron-histidine and boron-serine adduct complexes. Biochemistry 1993;32:12651-12655.
43. Kettner C, Mersinger L, Knabb R. The selective inhibition of thrombin by peptides of boroarginine. J Biol Chem 1990;265:18289-18297.
44. Wityak J, Earl RA, Abelman MM, Bethel YB, Fisher BN, Kauffman GS, Kettner CA, Ma P, McMillan JL, Mersinger LJ, Pesti J, Pierce ME, Rankin FW, Chorvat RJ, Confalone PN. Synthesis of thrombin inhibitor DuP 714. J Org Chem 1995;60:3717-3722.
45. (a) Gutheil WG, Bachovchin WW. Separation of L-proline-DL-boronylproline into its component diastereomers and kinetic analysis of their inhibition of dipeptidyl peptidase IV. A new method for the analysis of slow, tight binding inhibition. Biochemistry 1993;32:8723-8731.
46. (b) Sudmeier JL, Gunther UL, Gutheil WG, Coutts SJ, Snow RJ, Barton RW, Bachovchin WW. Solution structures of active and inactive forms of the DP IV (CD26) inhibitor pro-boropro determined by NMR spectroscopy. Biochemistry 1994;33:12427-12438.
47. (c) Snow RJ, Bachovchin WW, Barton RW, Campbell SJ, Coutts SJ, Freeman DM, Gutheil WG, Kelly TA, Kennedy CA, Krolikowski DA, Leonard SF, Pargelli CF, Tong L, Adams J. Studies on proline boronic acid dipeptide inhibitors of dipeptidyl peptidase IV: Identification of a cyclic species containing a B-N bond. J Am Chem Soc 1994;116:10860-10869.
48. Amssoms K, Oza SL, Ravaschino E, Yamani A, Lambeir A-M, Rajan P, Bal G, Rodriguez JB, Fairlamb AH, Augustyns K, Haemers A. Glutathione-like tripeptides as inhibitors of glutathionylspermidine synthetase. Part 1: Substitution of the glycine carboxylic acid group. Bioorg Med Chem Lett 2002;12:2553-2556.
49. Duncan K, Faraci SW, Matteson DS, Walsh CT. (1-Aminoethyl)boronic acid: A novel inhibitor for the Bacillus stearothermophilus alanine racemase and Salmonella typhimurium D-alanine:D-alanine ligase (ADP-forming). Biochemistry 1989;28:3541-3549.
50. Ness S, Martin R, Kindler AM, Paetzel M, Gold M, Jensen SE, Jones JB, Strynadka NCJ. Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 β-lactamase. Biochemistry 2000;39:5312-5321.
51. Martichonok V, Jones JB. Probing the specificity of the serine proteases subtilisin carlsberg and α-chymotrypsin with enantiomeric 1-acetamido boronic acids. An unexpected reversal of the normal "L"- stereoselectivity preference. J Am Chem Soc 1996;118:950-958.
52. Stoll VS, Eger BT, Hynes RC, Martichonok V, Jones JB, Pai EF. Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: Crystal structures of γ-chymotrypsin and subtilisin carlsberg complexes. Biochemistry 1998;37:451-462.
53. Shenvi AB. α-aminoboronic acid derivatives. US Patent No. 4,537,773, issued August 27, 1985. Chem Abstr 1986;104:19668.
54. Pivazyan AD, Matteson DS, Fabry-Asztalos L, Singh RP, Lin P, Blair W, Guo K, Robinson B, Prusoff WH. Inhibition of HIV-1 protease by a boron-modified polypeptide. Biochemical Pharmacology 2000;60:927-936.
55. Matteson DS, Hiscox WC, Fabry-Asztalos L, Kim G-Y, Siems WF III. Glass-catalyzed conversion of boronic esters of asymmetric diols to diol sulfites and amine complexes of boron halides. Organometallics 2001;20:2920-2923.
56. Vedejs E, Chapman RW, Fields SC, Lin S, Schrimpf MR. Conversion of arylboronic acids into potassium aryltrifluoroborates: Convenient precursors of arylboron difluoride lewis acids. J Org Chem 1995;60:3020-3027.
57. Matteson DS, Kim GY. Asymmetric alkyldifluoroboranes and their use in secondary amine synthesis. Org Lett 2002;4:2153-2155.
58. Kim BJ, Matteson DS. Cesium alkyltrifluoroborates from asymmetric boronic esters. Angew Chem 2004;116:3118-3120; Angew Chem Int Ed 2004;43:3056-3058.
59. Strickler M, Goldstein BM, Maxfield K, Shireman L, Kim G, Matteson DS, Jones JP. Crystallographic studies on the complex behavior of nicotine binding to P450cam (CYP101). Biochemistry 2003;42:11943-11950.
60. Matteson DS, Maliakal D, Pharazyn PS. Cesium alkyltrifluoroborates from asymmetric boronic esters. Synlett 2006; 3501-3503.